Breaking News: KDNY latest news.

Over a week ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
On The Fly	What You Missed On Wall Street On Tuesday » 16:30 05/16/23 05/16 16:30 05/16/23 16:30 HD Home Depot $282.36 / -6.04 (-2.09%) , AMGN Amgen $227.89 / -5.55 (-2.38%) , HZNP Horizon Therapeutics $96.35 / -15.91 (-14.17%) , COF Capital One $90.95 / +1.87 (+2.10%) , OXY Occidental Petroleum $58.13 / -0.39 (-0.67%) , BRK.A Berkshire Hathaway $495,000.00 / -1599.97 (-0.32%) , SHAK Shake Shack $67.23 / -3.045 (-4.33%) , SGEN Seagen $187.74 / -11.56 (-5.80%) , RXDX Prometheus $192.54 / -1.82 (-0.94%) , PFE Pfizer $37.00 / -0.17 (-0.46%) , MRK Merck $116.08 / -0.34 (-0.29%) , GILD Gilead $78.33 / -0.01 (-0.01%) , WBD Warner Bros. Discovery $12.16 / -0.645 (-5.04%) , RCL Royal Caribbean $76.48 / +0.42 (+0.55%) , CBSH Commerce Bancshares $48.37 / -1.37 (-2.75%) , PB Prosperity Bancshares $58.90 / -1.75 (-2.89%) , WAL Western Alliance $31.60 / +0.82 (+2.66%) , DAL Delta Air Lines $33.82 / +0.1 (+0.30%) , EADSY Airbus $34.10 / +0.58 (+1.73%) , CMCSA Comcast $39.73 / -0.48 (-1.19%) , AMZN Amazon.com $113.41 / +2.16 (+1.94%) , VOD Vodafone $10.25 / -0.97 (-8.65%) , UBS UBS $19.10 / -0.295 (-1.52%) , CS Credit Suisse / + , NVTS Navitas Semiconductor $7.99 / +1.36 (+20.51%) , VKTX Viking Therapeutics $24.65 / +2.68 (+12.20%) , KDNY Chinook Therapeutics $22.36 / -1.02 (-4.36%) , IQ iQIYI $5.50 / -0.48 (-8.03%) , BIDU Baidu $132.75 / +5.11 (+4.00%) , SSYS Stratasys $15.79 / +1.38 (+9.58%) , SE Sea Limited $72.45 / -15.665 (-17.78%) , ONON On Holding $30.18 / -3.265 (-9.76%) , ISPR Ispire Technology $8.64 / -0.26 (-2.92%) Get caught up quickly on… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options WBD WAL VOD VKTX UBS SSYS SHAK SGEN SE RXDX RCL PFE PB OXY ONON NVTS MRK KDNY ISPR IQ HD GILD EADSY DAL CS COF CMCSA CBSH BRK.A BIDU AMZN AMGN WBD Warner Bros. Discovery $12.16 / -0.645 (-5.04%) 05/05/23 Warner Bros. Discovery sees U.S. DTC business profitable in 2023 04/24/23 CNN's Don Lemon says he has been terminated from network 04/19/23 Capcom's 'Resident Evil 4' top-selling game in U.S. in March, says Circana 04/13/23 Warner Bros.' 'Suicide Squad' game delayed to February 2024 WAL Western Alliance $31.60 / +0.82 (+2.66%) 05/16/23 Western Alliance up 10% after issuing Q2-to-date update 05/16/23 Western Alliance reports quarter-to-date deposit growth over $2B as of May 12 05/11/23 FDIC proposes rule for special assessment on big banks for cost recovery 05/11/23 PacWest Bancorp down 21% after detailing deposit losses in early May VOD Vodafone $10.25 / -0.97 (-8.65%) 05/16/23 Vodafone down 5.5% to $10.60 after FY23 results 05/16/23 Vodafone to cut 11,000 jobs over three years 04/18/23 Citi collaborates with Vodafone to reduce emissions through supply chain 02/13/23 Liberty takes 4.92% stake in Vodafone, says not considering takeover VKTX Viking Therapeutics $24.65 / +2.68 (+12.20%) 05/16/23 Viking Therapeutics' VK2809 achieves endpoints in phase 2b NASH study 05/01/23 Viking Therapeutics CEO sells $1.01M in common stock 03/28/23 Viking Therapeutics initiates Phase 1 study of novel formulation of VK2735 03/28/23 Viking Therapeutics jumps 32% to $12.06 after Phase 1 VK2735 trial results UBS UBS $19.10 / -0.295 (-1.52%) 05/09/23 UBS: Michelle Bereaux named group integration officer 05/09/23 UBS: Todd Tuckner to succeed Sarah Youngwood as CFO at deal close 05/09/23 UBS: Credit Suisse CEO Ulrich Korner to join executive board at close 04/25/23 UBS says client activity levels 'could remain subdued' in Q2 SSYS Stratasys $15.79 / +1.38 (+9.58%) 05/16/23 Stratasys jumps 5% after reporting quarterly results, guidance above consensus 04/19/23 Nano Dimension says Stratasys news release misleads shareholders 04/17/23 Nano Dimension announces Israeli court decided board can lead, govern company 04/13/23 Stratasys board rejects Nano Dimension revised proposal of $20.05 per share SHAK Shake Shack $67.23 / -3.045 (-4.33%) 05/16/23 Shake Shack enters board cooperation agreement with Engaged Capital 04/19/23 Shake Shack teams with Harel Wizel and Yarzin Sella Group for Israel launch 03/22/23 Shake Shack to make entry into Canada in 2024 SGEN Seagen $187.74 / -11.56 (-5.80%) 04/26/23 Seagen says bladder cancer, Padcev data to highlight ASCO presentations 04/03/23 Seagen, Astellas announce FDA grants Padcev with Keytruda accelerated approval 03/13/23 Pfizer to acquire Seagen for $229 per share in cash SE Sea Limited $72.45 / -15.665 (-17.78%) 05/16/23 Sea Limited falls -15.7% 05/16/23 Sea Limited falls -13.3% 05/16/23 Sea Limited falls -12.9% RXDX Prometheus $192.54 / -1.82 (-0.94%) 04/16/23 Fly Intel: Top five weekend stock stories 04/16/23 Merck acquires Prometheus Biosciences for $200 per share 12/07/22 Prometheus announces results for PRA023 in APOLLO-CD Phase 2 study RCL Royal Caribbean $76.48 / +0.42 (+0.55%) 05/04/23 Royal Caribbean jumps 8% to $72.30 after Q1 results beat, FY23 guidance raised 05/04/23 Royal Caribbean sees FY23 CapEx $4.2B 05/04/23 Royal Caribbean CEO 'pleasantly surprised' with demand trends 02/07/23 Royal Caribbean jumps 5% to $72.54 after reporting Q4 results, FY23 guidance PFE Pfizer $37.00 / -0.17 (-0.46%) 05/14/23 Fly Intel: Top five weekend stock stories 05/11/23 GSK announces intention to sell up to 240M shares of Haleon 05/09/23 Pfizer, Thermo Fisher enter pact to expand access to NGS-based testing PB Prosperity Bancshares $58.90 / -1.75 (-2.89%) 04/17/23 Prosperity Bancshares' First Bancshares acquisition granted regulatory approvals 01/17/23 Prosperity Bancshares announces roughly 4.6M share buyback OXY Occidental Petroleum $58.13 / -0.39 (-0.67%) 05/16/23 Berkshire Hathaway acquires over 2.16M Occidental shares 05/10/23 Occidental Petroleum sees FY23 total company production 1.17-1.22 Mboed 05/10/23 Occidental Petroleum sees Q2 total company production 1.156-1.196 Mboed ONON On Holding $30.18 / -3.265 (-9.76%) 05/16/23 On Holding down 4% in pre-market at $32.20 after Q1 results 05/16/23 On Holding reports Q1 DTC sales up 64% 03/23/23 On Holding rises 12.9% 03/21/23 On Holding rises 28.1% NVTS Navitas Semiconductor $7.99 / +1.36 (+20.51%) 05/15/23 Navitas Semiconductor sees FY23 revenue to double 04/25/23 Navitas Semiconductor signs agreement with Mouser Electronics 04/12/23 Navitas to introduce expanded portfolio of GaN, SiC power products 04/03/23 Navitas Semiconductor, realme launch ultra-fast charging phone MRK Merck $116.08 / -0.34 (-0.29%) 05/16/23 OncoSec reports Type C meeting with FDA for melanoma treatment 05/15/23 Canadian Solar subsidiary signs aggregation deal for 100MW in Texas 05/09/23 ALX Oncology announces first patient dosed in Phase 2 trial of evorpacept KDNY Chinook Therapeutics $22.36 / -1.02 (-4.36%) 05/16/23 Chinook drops 7% to $21.76 after Muddy Waters short report 05/16/23 Chinook Therapeutics weakness attributed to short call 05/16/23 Chinook Therapeutics enters partnership with Ionis Pharmaceuticals 04/11/23 Chinook Therapeutics announces voluntary pause in dosing o CHK-336 ISPR Ispire Technology $8.64 / -0.26 (-2.92%) 05/16/23 Ispire Technology expects cash to fund operations in next 12 months 04/20/23 Ispire Technology announces strategic partnership with Cookies IQ iQIYI $5.50 / -0.48 (-8.03%) 02/22/23 iQIYI issues letter to investors regarding 2022 02/15/23 iQIYI enters framework agreement with Baidu on AI-generated content 01/17/23 iQIYI announces proposed offering of ADSs 12/27/22 China stocks rising with borders set to reopen on January 8 HD Home Depot $282.36 / -6.04 (-2.09%) 05/16/23 Home Depot says still seeing inflation in average ticket 05/16/23 Home Depot says big ticket comps down 6.5% y/y in Q1 05/16/23 Home Depot says observed more pressure across business vs. Q4 03/14/23 Home Depot names William Bastek EVP of merchandising, effective immediately GILD Gilead $78.33 / -0.01 (-0.01%) 05/15/23 Arcus Biosciences jumps 2% amid expanded inflammation pact with Gilead 05/15/23 Expanded Gilead- Arcus pact may result in up to $1B in payments to Arcus 05/15/23 Arcus to receive upfront payment of $35M from Gilead in expanded research pact 05/09/23 Gilead acquires XinThera, terms undisclosed EADSY Airbus $34.10 / +0.58 (+1.73%) 05/03/23 Spirit AeroSystems now sees full year cash flow usage of $100M-$150M 05/03/23 Spirit sees delivering fewer A320 ship sets this year than previously discussed 04/06/23 AerCap reports 252 assets leased, purchased and sold in Q1 04/06/23 Air Lease provides activity update for Q1 DAL Delta Air Lines $33.82 / +0.1 (+0.30%) 05/15/23 Tiger Management adds Nvidia in Q1, sells out of Toast and Chevron 04/13/23 Delta Air Lines still on trajectory for $7 in EPS in 2024 04/13/23 Delta doesn't share 'anxiety' about domestic demand for the summer 04/13/23 Delta Air Lines returning to y/y comparison metrics vs. 2019 CS Credit Suisse / + 04/25/23 UBS sees Credit Suisse combination strengthening position COF Capital One $90.95 / +1.87 (+2.10%) 05/15/23 Berkshire Hathaway takes stake in Capital One, exits RH 05/03/23 Capital One urges shareholders to reject mini-tender offer by TRC Capital 04/27/23 Capital One reports Q1 net interest margin of 6.6%, down 24 bps vs. Q4 04/09/23 Capital One received credit card termination notice from Walmart CMCSA Comcast $39.73 / -0.48 (-1.19%) 05/12/23 Musk confirms Linda Yaccarino hired as new CEO of Twitter 05/12/23 NBCUniversal announces Linda Yaccarino leaving company, effective immediately 05/02/23 Writers Guild of America goes on strike after studio talks fail CBSH Commerce Bancshares $48.37 / -1.37 (-2.75%) 02/03/23 Commerce Bancshares increases quarterly dividend to 27c per share from 25.2c 11/22/22 LPL Financial: Commerce Financial Advisors joins Institution Services Platform 11/18/22 Commerce Bancshares to acquire L.J. Hart & Company, terms undisclosed BRK.A Berkshire Hathaway $495,000.00 / -1599.97 (-0.32%) 05/07/23 Fly Intel: Top five weekend stock stories 04/30/23 Fly Intel: Top five weekend stock stories 04/25/23 Berkshire Hathaway's NetJets sued by pilot's union 03/27/23 Berkshire Hathaway acquires over 4.4M Occidental shares BIDU Baidu $132.75 / +5.11 (+4.00%) 05/16/23 Baidu aims to continue enhancing margins across all major operations 05/15/23 Paulson exits Bidu, cuts Horizon Therapeutics in Q1 04/24/23 Quhuo enters partnership with Baidu to gain access to ERNIE Bot 04/09/23 Fly Intel: Top five weekend stock stories AMZN Amazon.com $113.41 / +2.16 (+1.94%) 05/16/23 Latch says Ring-creator Jamie Siminoff to take over as CEO later this year 05/15/23 Appaloosa takes stake in FedEx, exits Aptiv 05/15/23 Lone Pine boosts Salesforce stake, reduces Visa, Mastercard stakes AMGN Amgen $227.89 / -5.55 (-2.38%) 05/16/23 Prometheus, Seagen slip after FTC sues to block Horizon acquisition 05/16/23 Horizon Therapeutics responds to FTC's action to block acquisition by Amgen 05/16/23 Amgen: Horizon Therapeutics deal poses 'no legitimate competitive issues' 05/16/23 Amgen 'disappointed' in FTC's decision to block Horizon Therapeutics deal HD AMGN HZNP COF OXY BRK.A SHAK SGEN RXDX PFE MRK GILD WBD RCL CBSH PB WAL DAL EADSY CMCSA AMZN VOD UBS CS NVTS VKTX KDNY IQ BIDU SSYS SE ONON ISPR HD Home Depot $282.36 / -6.04 (-2.09%) 05/16/23 Goldman Sachs Home Depot price target lowered to $330 from $340 at Goldman Sachs 05/16/23 Baird Home Depot price target lowered to $310 from $320 at Baird 05/16/23 Mizuho Stanley Black & Decker has negative read from Home Depot report, says Mizuho 05/16/23 Roth MKM Home Depot guide-down suggests Q2 acceleration not enough, says Roth MKM AMGN Amgen $227.89 / -5.55 (-2.38%) 05/16/23 Stifel Seagen likely to stay 'distanced' from deal price after FTC action, says Stifel 05/16/23 Jefferies Jefferies thinks Amgen-Horizon deal still gets done after 'speed bump' 05/03/23 Mizuho Amgen price target raised to $214 from $208 at Mizuho 05/01/23 Truist Coherus Biosciences initiated with a Buy at Truist HZNP Horizon Therapeutics $96.35 / -15.91 (-14.17%) 04/17/23 Wells Fargo Viridian Therapeutics initiated with an Overweight at Wells Fargo 03/29/23 Stifel Viridian Therapeutics initiated with a Buy at Stifel COF Capital One $90.95 / +1.87 (+2.10%) 04/28/23 BMO Capital Capital One price target lowered to $121 from $131 at BMO Capital 04/28/23 Credit Suisse Capital One price target lowered to $108 from $112 at Credit Suisse 04/28/23 Citi Capital One price target lowered to $119 from $126 at Citi 04/18/23 Citi Citi opens '30-day negative catalyst watch' on Capital One OXY Occidental Petroleum $58.13 / -0.39 (-0.67%) 05/11/23 Truist Occidental Petroleum price target lowered to $85 from $86 at Truist 04/21/23 Susquehanna Occidental Petroleum price target raised to $75 from $72 at Susquehanna 04/19/23 UBS Occidental Petroleum initiated with a Neutral at UBS 04/18/23 UBS Occidental Petroleum assumed with a Neutral at UBS BRK.A Berkshire Hathaway $495,000.00 / -1599.97 (-0.32%) 05/08/23 UBS Berkshire Hathaway price target raised to $565,580 from $556,612 at UBS 03/20/23 After rumors, Gordon Haskett suggests Buffett could 'start at home' with Ally 02/26/23 Keefe Bruyette Berkshire price target lowered to $480,000 from $500,000 at Keefe Bruyette 02/07/23 UBS Berkshire can outperform given uncertain economy, says UBS SHAK Shake Shack $67.23 / -3.045 (-4.33%) 05/16/23 Baird Shake Shack price target raised to $74 from $62 at Baird 05/08/23 UBS Shake Shack price target raised to $66 from $62 at UBS 05/05/23 Truist Shake Shack price target raised to $75 from $68 at Truist 05/05/23 Credit Suisse Shake Shack price target raised to $69 from $63 at Credit Suisse SGEN Seagen $187.74 / -11.56 (-5.80%) 05/10/23 Oppenheimer Oppenheimer upgrades Corbus Pharmaceuticals to Outperform with $22 target 04/28/23 Stifel Seagen price target raised to $229 from $157 at Stifel 04/04/23 BofA Padcev combo approval should alleviate concerns on Seagen deal, says BofA RXDX Prometheus $192.54 / -1.82 (-0.94%) 05/10/23 Jefferies Prometheus downgraded to Hold from Buy at Jefferies 04/18/23 Wells Fargo Prometheus downgraded to Equal Weight from Overweight at Wells Fargo 04/18/23 RBC Capital Prometheus downgraded to Sector Perform from Outperform at RBC Capital 04/17/23 Credit Suisse Prometheus downgraded to Neutral from Outperform at Credit Suisse PFE Pfizer $37.00 / -0.17 (-0.46%) 05/12/23 Capital One Olema Oncology price target raised to $20 from $16 at Capital One 05/11/23 Daiwa Pfizer downgraded to Neutral from Outperform at Daiwa 05/09/23 RBC Capital Maravai Lifesciences price target lowered to $20 from $22 at RBC Capital MRK Merck $116.08 / -0.34 (-0.29%) 05/01/23 Barclays Merck price target raised to $130 from $128 at Barclays GILD Gilead $78.33 / -0.01 (-0.01%) 05/16/23 BMO Capital Gilead upgraded to Outperform from Market Perform at BMO Capital 04/28/23 Piper Sandler Gilead assumed with an Overweight at Piper Sandler 04/12/23 Morgan Stanley Gilead price target raised to $85 from $81 at Morgan Stanley 04/05/23 Guggenheim InflaRx upgraded to Buy at Guggenheim after Gohibic gets COVID EUA WBD Warner Bros. Discovery $12.16 / -0.645 (-5.04%) 05/16/23 Barrington Warner Bros. Discovery upgraded to Outperform from Market Perform at Barrington 04/18/23 Atlantic Equities Comcast upgraded to Overweight from Neutral at Atlantic Equities 04/14/23 Wells Fargo Warner Bros. Discovery dip since Max reveal due to 'churn anxieties,' says Wells 04/10/23 Truist Warner Bros. Discovery initiated with a Buy at Truist RCL Royal Caribbean $76.48 / +0.42 (+0.55%) 05/16/23 Argus Royal Caribbean upgraded to Buy at Argus amid increase in cruise occupancy 05/16/23 Argus Royal Caribbean upgraded to Buy from Hold at Argus 05/05/23 Deutsche Bank Royal Caribbean price target raised to $71 from $65 at Deutsche Bank 05/05/23 Barclays Royal Caribbean price target raised to $100 from $88 at Barclays CBSH Commerce Bancshares $48.37 / -1.37 (-2.75%) 05/16/23 Morgan Stanley Commerce Bancshares downgraded to Underweight at Morgan Stanley 04/05/23 Morgan Stanley Commerce Bancshares price target lowered to $50 from $70 at Morgan Stanley 03/10/23 Morgan Stanley SVB Financial pressures 'highly idiosyncratic,' says Morgan Stanley 12/05/22 Morgan Stanley Commerce Bancshares initiated with an Equal Weight at Morgan Stanley PB Prosperity Bancshares $58.90 / -1.75 (-2.89%) 05/16/23 Morgan Stanley Prosperity Bancshares downgraded to Underweight at Morgan Stanley 05/03/23 Wolfe Research Prosperity Bancshares upgraded to Outperform from Underperform at Wolfe 04/06/23 Raymond James Prosperity Bancshares price target lowered to $70 from $85 at Raymond James 04/05/23 Morgan Stanley Prosperity Bancshares price target lowered to $58 from $69 at Morgan Stanley WAL Western Alliance $31.60 / +0.82 (+2.66%) 05/16/23 BofA Western Alliance resumed with a Buy at BofA 05/05/23 Hovde Group Hovde says Western Alliance seeing no 'negative feedback loop' from week's news 05/05/23 Wedbush Western Alliance removed from Best Ideas List at Wedbush 05/05/23 JPMorgan Western Alliance upgraded to Overweight from Neutral at JPMorgan DAL Delta Air Lines $33.82 / +0.1 (+0.30%) 05/08/23 JPMorgan Delta Air Lines price target lowered to $69 from $81 at JPMorgan 04/14/23 BofA Delta Air Lines price target lowered to $40 from $43 at BofA 04/14/23 Morgan Stanley Delta Air Lines price target raised to $70 from $65 at Morgan Stanley 04/13/23 Seaport Research Delta Air Lines price target raised to $50 from $49 at Seaport Research EADSY Airbus $34.10 / +0.58 (+1.73%) 02/07/23 Berenberg Airbus downgraded to Sell from Hold at Berenberg 01/31/23 UBS Airbus downgraded to Sell from Buy at UBS 01/27/23 Kepler Cheuvreux Airbus downgraded to Reduce from Hold at Kepler Cheuvreux 01/26/23 Jefferies Airbus downgraded to Hold from Buy at Jefferies CMCSA Comcast $39.73 / -0.48 (-1.19%) 05/03/23 Citi Citi places 'Positive Catalyst Watch' on AT&T ahead of disclosures 05/02/23 Deutsche Bank Comcast price target raised to $55 from $50 at Deutsche Bank 05/02/23 Citi Comcast price target raised to $47 from $45 at Citi 05/01/23 BofA Comcast upgraded to Buy from Neutral at BofA AMZN Amazon.com $113.41 / +2.16 (+1.94%) 05/08/23 Loop Capital Amazon.com AWS slowdown transitory, says Loop Capital 05/03/23 Roth MKM Veritone price target lowered to $8 from $11 at Roth MKM 05/03/23 Oppenheimer Microsoft's differentiated AI strategy boosts secular growth, says Oppenheimer 05/01/23 Barclays Amazon.com price target lowered to $140 from $150 at Barclays VOD Vodafone $10.25 / -0.97 (-8.65%) 05/12/23 JPMorgan Vodafone price target lowered to 95 GBp from 100 GBp at JPMorgan 04/14/23 JPMorgan Vodafone price target raised to 100 GBp from 95 GBp at JPMorgan 04/04/23 Citi Vodafone resumed with a Neutral at Citi 03/21/23 Deutsche Bank Vodafone price target lowered to 185 GBp from 195 GBp at Deutsche Bank UBS UBS $19.10 / -0.295 (-1.52%) 04/26/23 Barclays UBS price target lowered to CHF 16.50 from CHF 17 at Barclays 04/14/23 Barclays Julius Baer upgraded to Overweight from Equal Weight at Barclays 04/11/23 JPMorgan UBS price target raised to CHF 27 from CHF 23 at JPMorgan 03/29/23 RBC Capital UBS downgraded to Sector Perform from Outperform at RBC Capital CS Credit Suisse / + 04/26/23 Barclays Credit Suisse price target lowered to CHF 0.73 from CHF 0.80 at Barclays 04/14/23 Barclays Credit Suisse price target lowered to CHF 0.80 from CHF 2.30 at Barclays 04/11/23 Redburn Credit Suisse upgraded to Neutral from Sell at Redburn NVTS Navitas Semiconductor $7.99 / +1.36 (+20.51%) 05/16/23 Deutsche Bank Navitas Semiconductor price target raised to $9 from $8 at Deutsche Bank 05/16/23 BofA Navitas Semiconductor price target raised to $8 from $7 at BofA 02/24/23 Deutsche Bank Navitas Semiconductor price target raised to $8 from $6 at Deutsche Bank 02/24/23 Baird Navitas Semiconductor price target raised to $10 from $8 at Baird VKTX Viking Therapeutics $24.65 / +2.68 (+12.20%) 05/16/23 Stifel Viking Therapeutics price target raised to $30 from $25 at Stifel 05/03/23 Roth MKM Viking Therapeutics price target raised to $24 from $19 at Roth MKM 04/27/23 H.C. Wainwright Viking Therapeutics price target raised to $33 from $21 at H.C. Wainwright 04/25/23 Oppenheimer Viking Therapeutics price target raised to $35 from $30 at Oppenheimer KDNY Chinook Therapeutics $22.36 / -1.02 (-4.36%) 05/10/23 H.C. Wainwright Chinook Therapeutics price target raised to $32 from $31 at H.C. Wainwright 05/02/23 Guggenheim Chinook Therapeutics price target lowered to $35 from $43 at Guggenheim 03/06/23 Piper Sandler Chinook Therapeutics initiated with an Overweight at Piper Sandler 02/28/23 Guggenheim Guggenheim starts Chinook Therapeutics at Buy, 'bullish' on IgAN market IQ iQIYI $5.50 / -0.48 (-8.03%) 04/06/23 OTR Global iQIYI upgraded to Mixed from Negative view at OTR Global 03/06/23 Goldman Sachs iQIYI upgraded to Buy at Goldman ahead of revenue acceleration 03/06/23 Goldman Sachs iQIYI upgraded to Buy from Neutral at Goldman Sachs 03/02/23 BofA iQIYI upgraded to Buy at BofA on content quality BIDU Baidu $132.75 / +5.11 (+4.00%) 05/11/23 OTR Global Baidu upgraded to Positive from Mixed view at OTR Global 05/09/23 Mizuho Baidu price target lowered to $170 from $190 at Mizuho 05/01/23 Bernstein Baidu upgraded to Outperform at Bernstein on GPT innovation tailwinds 05/01/23 Bernstein Baidu upgraded to Outperform from Market Perform at Bernstein SSYS Stratasys $15.79 / +1.38 (+9.58%) 03/10/23 Lake Street Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street 03/03/23 Lake Street Stratasys price target raised to $22 from $20 at Lake Street 01/04/23 Needham Needham upgrades Stratasys to Buy, sees valuation reflect more challenging 2023 01/04/23 Needham Stratasys upgraded to Buy from Hold at Needham SE Sea Limited $72.45 / -15.665 (-17.78%) 04/20/23 Benchmark Sea Limited initiated with a Buy at Benchmark 04/20/23 UBS Sea Limited downgraded to Neutral from Buy at UBS 04/13/23 Loop Capital Sea Limited price target raised to $88 from $62 at Loop Capital 03/22/23 Bernstein Sea Limited price target raised to $100 from $80 at Bernstein ONON On Holding $30.18 / -3.265 (-9.76%) 05/16/23 Stifel On Holding price target raised to $36 after Q1 report at Stifel 04/19/23 Piper Sandler On Holding price target raised to $37 from $33 at Piper Sandler 04/05/23 Baird Baird downgrades On Holding to Neutral after rally 04/05/23 Baird On Holding downgraded to Neutral from Outperform at Baird ISPR Ispire Technology $8.64 / -0.26 (-2.92%) WBD WAL VOD VKTX UBS SSYS SHAK SGEN SE RXDX RCL PFE PB OXY ONON NVTS MRK KDNY ISPR IQ HZNP HD GILD EADSY DAL CS COF CMCSA CBSH BRK.A BIDU AMZN AMGN WBD Warner Bros. Discovery $12.16 / -0.645 (-5.04%) 05/05/23 Warner Bros. Discovery reports Q1 EPS (44c), consensus 1c 05/04/23 Notable companies reporting before tomorrow's open 02/23/23 Warner Bros. Discovery sees FY23 adjusted EBITDA low- to mid-$11B range WAL Western Alliance $31.60 / +0.82 (+2.66%) 04/18/23 Western Alliance reports adjusted Q1 revenue $712.2M, consensus $666.4M 04/18/23 Western Alliance reports Q1 adjusted EPS $2.30, consensus $2.04 04/18/23 Notable companies reporting after market close 01/24/23 Western Alliance reports Q4 EPS $2.67, consensus $2.66 VOD Vodafone $10.25 / -0.97 (-8.65%) 05/16/23 Vodafone sees FY24 adjusted EBITDA around EUR 13.3B vs. EUR14.7B in FY23 05/16/23 Vodafone reports FY23 EPS EUR 11.5c vs. EUR 11.7c last year VKTX Viking Therapeutics $24.65 / +2.68 (+12.20%) 04/26/23 Viking Therapeutics reports Q1 EPS (25c), consensus (24c) 02/08/23 Viking Therapeutics reports Q4 EPS (26c), consensus (23c) UBS UBS $19.10 / -0.295 (-1.52%) 04/25/23 UBS reports Q1 EPS 32c, profit before tax $1.5B 04/24/23 Credit Suisse reports Q1 net revenue CHF 2.73B vs. CHF 4.58B last year 01/31/23 UBS reports Q4 EPS 50c, profit before tax $1.9B SSYS Stratasys $15.79 / +1.38 (+9.58%) 05/16/23 Stratasys sees FY23 EPS 12c-24c, consensus 16c 05/16/23 Stratasys reports Q1 EPS 2c, consensus (6c) 03/02/23 Stratasys sees FY23 EPS 12c-24c, consensus 20c 03/02/23 Stratasys reports Q4 EPS 7c, consensus 3c SHAK Shake Shack $67.23 / -3.045 (-4.33%) 05/04/23 Shake Shack reports Q1 EPS 1c, consensus (8c) 02/17/23 Shake Shack reports Q4 EPS (6c) vs. (11c) y/y 01/10/23 Shake Shack reports preliminary Q4 revenue $238.5M, consensus $237.56M SGEN Seagen $187.74 / -11.56 (-5.80%) 04/27/23 Seagen reports Q1 EPS (93c), consensus (82c) 02/15/23 Seagen sees FY23 revenue $2.14B-$2.24B, consensus $2.3B 02/15/23 Seagen reports Q4 EPS (80c), consensus ($1.04) SE Sea Limited $72.45 / -15.665 (-17.78%) 05/16/23 Sea Limited reports Q1 EPS 16c, consensus 39c 03/07/23 Sea Limited reports Q4 EPS 72c, consensus (79c) RXDX Prometheus $192.54 / -1.82 (-0.94%) 05/09/23 Prometheus reports Q1 EPS (86c), consensus (91c) 02/28/23 Prometheus reports Q4 EPS (90c), consensus (92c) RCL Royal Caribbean $76.48 / +0.42 (+0.55%) 05/04/23 Royal Caribbean sees Q2 adjusted EPS $1.50 to $1.60, consensus 94c 05/04/23 Royal Caribbean raises FY23 adjusted EPS view to $4.40-$4.80 from $3.00-$3.60 05/04/23 Royal Caribbean reports Q1 adjusted EPS (23c), consensus (70c) 02/07/23 Royal Caribbean sees FY23 adjusted EPS $3.00-$3.60, consensus $3.25 PFE Pfizer $37.00 / -0.17 (-0.46%) 05/02/23 Pfizer backs FY23 adjusted EPS view $3.25-$3.45, consensus $3.36 05/02/23 Pfizer reports Q1 adjusted EPS $1.23, consensus 98c 03/15/23 Royalty Pharma raises FY23 adjusted cash receipt guidance to $2.85B-$2.95B 01/31/23 Pfizer sees FY23 adjusted EPS $3.25-$3.45, consensus $4.44 PB Prosperity Bancshares $58.90 / -1.75 (-2.89%) 04/26/23 Prosperity Bancshares reports Q1 EPS $1.37, consensus $1.34 01/25/23 Prosperity Bancshares reports Q4 EPS $1.51, consensus $1.49 OXY Occidental Petroleum $58.13 / -0.39 (-0.67%) 05/09/23 Occidental Petroleum reports Q1 adjusted EPS $1.09, consensus $1.24 02/27/23 Occidental Petroleum reports Q4 adjusted EPS $1.61, consensus $1.81 ONON On Holding $30.18 / -3.265 (-9.76%) 05/16/23 On Holding raises FY23 revenue view to at least CHF 1.74B from at least CHF 1.B 05/16/23 On Holding reports Q1 adjusted EPS CHF0.05 vs. (CHF0.10) last year 03/21/23 On Holding sees FY23 revenue of 'at least' CHF 1.7B vs. CHF 1.22B last year 03/21/23 On Holding reports Q4 EPS CHF0.02 vs. (CHF0.04) last year NVTS Navitas Semiconductor $7.99 / +1.36 (+20.51%) 05/15/23 Navitas Semiconductor sees Q2 revenue $16M-$17M, consensus $15.17M 05/15/23 Navitas Semiconductor reports Q1 EPS (7c), consensus (8c) 02/23/23 Navitas Semiconductor sees Q1 revenue flat, consensus $13.05M 02/23/23 Navitas Semiconductor reports Q4 EPS (6c), consensus (8c) MRK Merck $116.08 / -0.34 (-0.29%) 04/27/23 Merck narrows FY23 revenue view to $57.7B-$58.9B from $57.2B-$58.7B 04/27/23 Merck reports Q1 adjusted EPS $1.40, consensus $1.32 04/26/23 Notable companies reporting before tomorrow's open KDNY Chinook Therapeutics $22.36 / -1.02 (-4.36%) 05/09/23 Chinook Therapeutics reports Q1 EPS (85c), consensus (79c) 02/27/23 Chinook Therapeutics reports Q4 EPS (90c), consensus (79c) ISPR Ispire Technology $8.64 / -0.26 (-2.92%) 05/16/23 Ispire Technology sees cannabis vaping product revenue $12M-$15M in Q4 05/16/23 Ispire Technology reports Q3 EPS (6c) vs. (2c) last year IQ iQIYI $5.50 / -0.48 (-8.03%) 05/16/23 iQIYI reports Q1 EPS RMB 0.97 vs. RMB 0.20 last year 11/22/22 iQIYI reports Q3 EPS 3c, consensus (1c) HZNP Horizon Therapeutics $96.35 / -15.91 (-14.17%) 05/03/23 Horizon Therapeutics: Q1 Tepezza net sales $405.3M 05/03/23 Horizon Therapeutics reports Q1 EPS 83c, consensus $1.12 HD Home Depot $282.36 / -6.04 (-2.09%) 05/16/23 Home Depot cuts FY23 EPS view to down 7%-13% from down mid-single digits percent 05/16/23 Home Depot reports Q1 EPS $3.82, consensus $3.80 05/15/23 Notable companies reporting before tomorrow's open GILD Gilead $78.33 / -0.01 (-0.01%) 05/15/23 Gilead: Arcus deal may reduce Gilead's FY23 GAAP and non-GAAP EPS by 2c 04/27/23 Gilead backs FY23 adjusted EPS view $6.60-$7.00, consensus $6.84 04/27/23 Gilead reports Q1 Biktarvy sales up 24% y/y 04/27/23 Gilead Sciences reports Q1 adjusted EPS $1.37, consensus $1.54 EADSY Airbus $34.10 / +0.58 (+1.73%) 05/03/23 Airbus says guidance issued in February remains unchanged 05/03/23 Airbus reports Q1 EPS EUR 0.59 vs. EUR 1.55 last year 02/16/23 Airbus sees FY23 EBIT adjusted EUR 6B 02/16/23 Airbus reports FY22 revenue EUR 58.8B, EBIT adjusted up 16% to EUR 5.6B DAL Delta Air Lines $33.82 / +0.1 (+0.30%) 04/13/23 Delta Air Lines sees Q2 revenue $14.2B-$14.4B, consensus $14.08B 04/13/23 Delta Air Lines backs FY23 EPS view $5.00-$6.00, consensus $5.39 04/13/23 Delta Air Lines sees Q2 EPS $2.00-$2.25, consensus $1.65 04/13/23 Delta Air Lines reports Q1 adjusted EPS 25c, consensus 30c CS Credit Suisse / + 02/09/23 Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year COF Capital One $90.95 / +1.87 (+2.10%) 04/27/23 Capital One reports Q1 EPS $2.31, consensus $3.92 01/24/23 Capital One reports Q4 adjusted EPS $2.82, consensus $3.84 01/24/23 Notable companies reporting after market close CMCSA Comcast $39.73 / -0.48 (-1.19%) 04/27/23 Comcast reports Q1 adjusted EPS 92c, consensus 82c 01/26/23 Comcast reports Q4 adjusted EPS 82c, consensus 77c CBSH Commerce Bancshares $48.37 / -1.37 (-2.75%) 04/18/23 Commerce Bancshares reports Q1 EPS 95c, consensus 92c 01/19/23 Commerce Bancshares reports Q4 EPS $1.04, consensus $1.03 BRK.A Berkshire Hathaway $495,000.00 / -1599.97 (-0.32%) 05/07/23 Berkshire Hathaway reports jump in earnings, cash hoard tops $130B 02/26/23 Berkshire Hathaway Q4 operating earnings fall 8%, cash hoard tops $128B BIDU Baidu $132.75 / +5.11 (+4.00%) 05/16/23 Baidu reports Q1 EPS $2.34, consensus $1.79 02/22/23 Baidu reports Q4 EPS $2.21, consensus $2.00 AMZN Amazon.com $113.41 / +2.16 (+1.94%) 04/27/23 Amazon sees Q2 revenue $127B-$133B, consensus $129.83B 04/27/23 Amazon reports Q1 EPS 31c with Rivian loss, consensus 21c 02/02/23 Amazon sees Q1 revenue $121B-$126B, consensus $125.11B AMGN Amgen $227.89 / -5.55 (-2.38%) 04/27/23 Amgen raises FY23 adjusted EPS view to $17.60-$18.70 from $17.40-$18.60 04/27/23 Amgen reports Q1 adjusted EPS $3.98, consensus $3.85 04/27/23 Notable companies reporting after market close 03/01/23 Horizon Therapeutics reports Q4 EPS $1.21, consensus $1.09 30 Mar 17 Jan 09 Dec 25 May WBD WAL VOD VKTX UBS SHAK SGEN RCL PFE OXY MRK KDNY IQ HZNP HD EADSY DAL COF CMCSA BRK.A BIDU AMZN AMGN WBD Warner Bros. Discovery $12.16 / -0.645 (-5.04%) 05/08/23 'Hogwarts Legacy' back in first place in U.K. boxed charts, GI.biz says 05/01/23 EA's 'Jedi: Survivor' achieves top spot in U.K. boxed sales, GI.biz reports 04/24/23 Embracer's 'Dead Island 2' leads U.K. physical game sale charts, GI.biz says 04/20/23 Paramount says WBD owes $52M for 'South Park' streaming rights, TC reports WAL Western Alliance $31.60 / +0.82 (+2.66%) 05/04/23 State, fed officials assessing possible bank share 'manipulation,' Reuters says 05/04/23 Western Alliance tells Bloomberg 'no truth' to report of exploring options 05/04/23 Western Alliance tells Bloomberg report of deal talks 'absolutely false' 05/04/23 Western Alliance exploring options, including potential sale, FT reports VOD Vodafone $10.25 / -0.97 (-8.65%) 05/15/23 Vodafone seeks buyer for minority stake in IOT division, Sky News says 05/05/23 Top Vodafone shareholder weighs boosting stake up to 25%, Bloomberg says 04/26/23 Iliad revives talks with Vodafone on potential Europe deal, Bloomberg says 04/06/23 Vodafone attracting interest for $4B Spanish business, Bloomberg reports VKTX Viking Therapeutics $24.65 / +2.68 (+12.20%) 01/02/23 Viking sued Ascletis alleging stolen trade secrets, Reuters reports UBS UBS $19.10 / -0.295 (-1.52%) 05/16/23 EU to give unconditional approval to UBS-Credit Suisse deal, Reuters says 05/12/23 UBS prioritizes integration of Credit Suisse investment bank, FT reports 05/04/23 UBS considering options for Credit Suisse's Swiss bank, Reuters reports 05/03/23 UBS considered possible Credit Suisse deal as early as December, Reuters reports SHAK Shake Shack $67.23 / -3.045 (-4.33%) 05/14/23 Engaged built 6.6% stake in Shake Shack, seeks board seats, WSJ says 05/14/23 Engaged Capital built 6.6% stake in Shake Shack, seeks board seats 01/31/23 Beef prices to spike with U.S. cattle herd falling, Bloomberg says 01/11/23 Subway looks into sale that could value company at over $10B, WSJ says SGEN Seagen $187.74 / -11.56 (-5.80%) 02/27/23 Pfizer in talks to buy Seagen in deal that may be valued at over $30B, WSJ says RCL Royal Caribbean $76.48 / +0.42 (+0.55%) 03/30/23 Cruise line passengers claim sexual assault by crew members, BuzzFeed News says PFE Pfizer $37.00 / -0.17 (-0.46%) 05/14/23 Pfizer Pfizer, Stryker have strong growth prospects, Barron's says 05/10/23 BioNTech pancreatic cancer vaccine 'shows promise' in small trial, NYT says 04/11/23 Drugmakers call for abortion pill ruling reversal, Reuters reports 03/21/23 FDA moving towards authorizing second omicron booster, WSJ reports OXY Occidental Petroleum $58.13 / -0.39 (-0.67%) 05/08/23 Occidental Petroleum slips as Buffett says Berkshire won't seek control 04/11/23 Occidental Petroleum works on billion-dollar climate moonshot, WSJ reports MRK Merck $116.08 / -0.34 (-0.29%) 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports 01/11/23 Merck, Pfizer rebuff China's efforts to cut Covid drug prices, Bloomberg says 12/30/22 Merck's Covid treatment gets conditional approval in China, Reuters reports KDNY Chinook Therapeutics $22.36 / -1.02 (-4.36%) 05/16/23 Muddy Waters short Chinook, says atrasentan 'highly unlikely' to be approved 05/16/23 Chinook's atrasentan shows no sign of renal repair, Muddy Water says 05/16/23 Muddy Waters announces short position in Chinook Therapeutics IQ iQIYI $5.50 / -0.48 (-8.03%) 12/22/22 China seen cutting quarantine for inbound overseas travelers, Global Times says HZNP Horizon Therapeutics $96.35 / -15.91 (-14.17%) 01/26/23 Warren writes FTC over concerns of two pharma deals, Reuters reports HD Home Depot $282.36 / -6.04 (-2.09%) 01/28/23 Lowe's is catching up to Home Depot, stock price to follow, Barron's says EADSY Airbus $34.10 / +0.58 (+1.73%) 04/18/23 Airbus advises airlines of delivery delays for 2024, Reuters reports 04/06/23 Boeing to boost 737 production sooner than expected, Bloomberg says DAL Delta Air Lines $33.82 / +0.1 (+0.30%) 05/15/23 Delta in talks with Airbus for significant aircraft order, Bloomberg reports 05/15/23 Delta in talks with Airbus for significant aircraft order, Bloomberg reports 05/08/23 Biden aims to require airlines compensate for travel disruptions, NBC reports 03/07/23 U.S. to lift COVID testing requirements for travelers from China, WaPo reports COF Capital One $90.95 / +1.87 (+2.10%) 04/21/23 Federal Reserve debates closing loophole masking securities losses, WSJ reports 04/07/23 Walmart sues to end credit-card partnership with Capital One, WSJ reports 01/23/23 Banks teaming up to launch digital wallet to compete with PayPal, WSJ reports 01/19/23 Capital One slashes over 1,100 technology positions, Bloomberg reports CMCSA Comcast $39.73 / -0.48 (-1.19%) 05/16/23 Comcast 'likely' to sell Hulu stake in 2024 to Disney, CNBC reports 05/16/23 Peacock will exclusively carry one NFL playoff game next season, WSJ reports 05/14/23 New Zelda good for Nintendo stock, boost still to come, Barron's says 05/11/23 NBCUniversal's Yaccarino in talks to become Twitter CEO, WSJ says BRK.A Berkshire Hathaway $495,000.00 / -1599.97 (-0.32%) 05/07/23 Buffett says Apple is Berkshire portfolio's best business, Reuters reports 04/30/23 Berkshire stock should be bought ahead of annual meeting, Barron's says 12/17/22 Amazon, Google among Barron's 10 favorite stocks for 2023 11/20/22 JPMorgan taps Walmart exec for new health venture, Bloomberg says BIDU Baidu $132.75 / +5.11 (+4.00%) 04/09/23 Baidu sues Apple, app developers over fake Ernie bot apps, Reuters says 04/02/23 TikTok not the last Chinese company to be target, Barron's says 03/16/23 Baidu's Ernie Bot disappoints investors at unveiling, Reuters reports 03/09/23 Some employees sell Baidu stock ahead of ChatGPT equivalent launch, WSJ says AMZN Amazon.com $113.41 / +2.16 (+1.94%) 05/16/23 Tech companies resumed hiring foreign workers this week, Lee Fang reports 05/16/23 Amazon plans to add ChatGPT-like search to online store, Bloomberg reports 05/15/23 C3.ai CEO tells CNBC audit committee found short report 'just unmitigated muck' 05/14/23 Amazon overhauls delivery network to dispatch packages faster, cheaper, WSJ says AMGN Amgen $227.89 / -5.55 (-2.38%) 05/16/23 FTC will sue to block Horizon Therapeutics takeover by Amgen, Bloomberg says 05/15/23 FTC looks to block Horizon Therapeutics deal with Amgen, Capitol Forum says 05/15/23 FTC looks to blow Horizon Therapeutics acquisition by Amgen, Capitol Forum says 01/31/23 AbbVie's Humira drug faces competition in the U.S., FT reports WBD WAL VKTX UBS SSYS SHAK SGEN SE RXDX RCL PFE PB OXY ONON NVTS MRK ISPR IQ HZNP HD GILD EADSY DAL COF CMCSA CBSH BRK.A BIDU AMGN WBD Warner Bros. Discovery $12.16 / -0.645 (-5.04%) 05/14/23 Box Office Battle: ‘Guardians of the Galaxy Vol.3’ stays atop with $60.5M WAL Western Alliance $31.60 / +0.82 (+2.66%) 05/11/23 What You Missed On Wall Street On Thursday VKTX Viking Therapeutics $24.65 / +2.68 (+12.20%) 03/31/23 What You Missed On Wall Street On Friday 03/31/23 What You Missed On Wall Street This Morning UBS UBS $19.10 / -0.295 (-1.52%) 05/04/23 What You Missed On Wall Street This Morning SSYS Stratasys $15.79 / +1.38 (+9.58%) 03/29/23 What You Missed On Wall Street On Wednesday 03/29/23 What You Missed On Wall Street This Morning SHAK Shake Shack $67.23 / -3.045 (-4.33%) 05/15/23 What You Missed On Wall Street On Monday 05/15/23 What You Missed On Wall Street This Morning SGEN Seagen $187.74 / -11.56 (-5.80%) 03/14/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/13/23 What You Missed On Wall Street On Monday 03/13/23 What You Missed On Wall Street This Morning SE Sea Limited $72.45 / -15.665 (-17.78%) 03/07/23 What You Missed On Wall Street On Tuesday 03/07/23 What You Missed On Wall Street This Morning RXDX Prometheus $192.54 / -1.82 (-0.94%) 04/19/23 Biotech Alert: Searches spiking for these stocks today 04/17/23 What You Missed On Wall Street This Morning 04/17/23 Fly Intel: Pre-market Movers RCL Royal Caribbean $76.48 / +0.42 (+0.55%) 02/08/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations PFE Pfizer $37.00 / -0.17 (-0.46%) 05/02/23 What You Missed On Wall Street On Tuesday 05/02/23 What You Missed On Wall Street This Morning 03/21/23 What You Missed On Wall Street On Tuesday PB Prosperity Bancshares $58.90 / -1.75 (-2.89%) 03/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations OXY Occidental Petroleum $58.13 / -0.39 (-0.67%) 05/10/23 Fly Intel: Pre-market Movers 05/08/23 What You Missed On Wall Street On Monday ONON On Holding $30.18 / -3.265 (-9.76%) 04/05/23 What You Missed On Wall Street This Morning 03/23/23 What You Missed On Wall Street On Thursday NVTS Navitas Semiconductor $7.99 / +1.36 (+20.51%) 02/24/23 What You Missed On Wall Street On Friday 02/24/23 What You Missed On Wall Street This Morning MRK Merck $116.08 / -0.34 (-0.29%) 04/27/23 Fly Intel: Pre-market Movers 04/17/23 What You Missed On Wall Street On Monday ISPR Ispire Technology $8.64 / -0.26 (-2.92%) 04/09/23 Opening Day: Tobacco vape maker Ispire goes public after downsizing IPO by 50% IQ iQIYI $5.50 / -0.48 (-8.03%) 01/17/23 What You Missed On Wall Street On Tuesday 01/17/23 What You Missed On Wall Street This Morning HZNP Horizon Therapeutics $96.35 / -15.91 (-14.17%) 05/03/23 What You Missed On Wall Street This Morning HD Home Depot $282.36 / -6.04 (-2.09%) 05/16/23 What You Missed On Wall Street On Tuesday 05/16/23 What You Missed On Wall Street This Morning 05/16/23 Fly Intel: Pre-market Movers 05/15/23 Here's what Wall Street is saying about Home Depot, Lowe's ahead of earnings GILD Gilead $78.33 / -0.01 (-0.01%) 05/16/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations EADSY Airbus $34.10 / +0.58 (+1.73%) 04/18/23 What You Missed On Wall Street This Morning DAL Delta Air Lines $33.82 / +0.1 (+0.30%) 04/13/23 What You Missed On Wall Street On Thursday COF Capital One $90.95 / +1.87 (+2.10%) 05/15/23 Fly Intel: After-Hours Movers CMCSA Comcast $39.73 / -0.48 (-1.19%) 05/12/23 What You Missed On Wall Street On Friday 05/12/23 What You Missed On Wall Street This Morning CBSH Commerce Bancshares $48.37 / -1.37 (-2.75%) 01/30/23 Fly Insider: Clear Channel, Jabil among notable insider trades this week BRK.A Berkshire Hathaway $495,000.00 / -1599.97 (-0.32%) 05/08/23 What You Missed On Wall Street This Morning BIDU Baidu $132.75 / +5.11 (+4.00%) 03/17/23 What You Missed On Wall Street On Friday AMGN Amgen $227.89 / -5.55 (-2.38%) 04/27/23 Fly Intel: After-Hours Movers 06/28/23 Biotech/Biopharma 05/16/23 Global Healthcare Conference 2023 05/16/23 Inaugural Technology, Media & Telecom Conference 05/19/23 ATS 2023 International Conference 06/02/23 Truist Hosted Company Events at 2023 ASCO Annual Meeting 05/16/23 Vodafone - VOD 05/16/23 iQIYI - IQ 05/16/23 Sea Limited - SE 05/16/23 On Holding - ONON 05/16/23 Baidu - BIDU 05/16/23 Stratasys - SSYS 05/16/23 Home Depot - HD 08/01/23 Merck - MRK 05/18/23 The Home Depot, Inc. 05/19/23 Amgen Inc. 05/23/23 Merck & Co. Inc. 05/24/23 Viking Therapeutics 05/24/23 Amazon.com, Inc. 05/30/23 Seagen Inc 05/31/23 Seagen Inc 06/01/23 Royal Caribbean Cruises Ltd. 06/07/23 Comcast Corporation 06/08/23 Delta Airlines Inc. 06/08/23 Navitas Semiconductor Corp 06/09/23 Chinook Therapeutics Inc 06/13/23 Viking Therapeutics, Inc. 06/14/23 Western Alliance Bancorporation 06/15/23 Viking Therapeutics 07/10/23 Prometheus 07/11/23 Prometheus WBD WAL VOD VKTX UBS SE RXDX RCL PFE OXY ONON MRK IQ HZNP HD GILD DAL CS COF CMCSA BIDU AMZN AMGN WBD Warner Bros. Discovery $12.16 / -0.645 (-5.04%) 05/11/23 Warner Bros. Discovery put volume heavy and directionally bearish 05/08/23 Warner Bros. Discovery call volume above normal and directionally bullish 04/28/23 Warner Bros. Discovery call volume above normal and directionally bullish 04/25/23 Warner Bros. Discovery call volume above normal and directionally bullish WAL Western Alliance $31.60 / +0.82 (+2.66%) 05/11/23 Unusually active option classes on open May 11th 05/09/23 Largest borrow rate increases among liquid names 05/05/23 Unusually active option classes on open May 5th 05/04/23 Western Alliance put volume heavy and directionally bearish VOD Vodafone $10.25 / -0.97 (-8.65%) 05/15/23 Vodafone call volume above normal and directionally bullish 03/17/23 Largest borrow rate increases among liquid names 03/03/23 Largest borrow rate increases among liquid names 02/15/23 Vodafone call volume above normal and directionally bullish VKTX Viking Therapeutics $24.65 / +2.68 (+12.20%) 04/21/23 Viking Therapeutics call volume above normal and directionally bullish 04/18/23 Viking Therapeutics call volume above normal and directionally bullish 04/10/23 Viking Therapeutics call volume above normal and directionally bullish UBS UBS $19.10 / -0.295 (-1.52%) 05/04/23 UBS put volume heavy and directionally bearish 04/12/23 Unusually active option classes on open April 12th 04/12/23 Largest borrow rate increases among liquid names 03/31/23 UBS call volume above normal and directionally bullish SE Sea Limited $72.45 / -15.665 (-17.78%) 05/15/23 Unusually active option classes on open May 15th 05/08/23 Unusually active option classes on open May 8th 03/08/23 Sea Limited call buyer realizes 30% same-day gains 03/07/23 Unusually active option classes on open March 7th RXDX Prometheus $192.54 / -1.82 (-0.94%) 05/11/23 Largest borrow rate increases among liquid names 12/05/22 Prometheus Biosciences put volume heavy and directionally bearish 11/22/22 Unusually active option classes on open November 22nd RCL Royal Caribbean $76.48 / +0.42 (+0.55%) 05/04/23 Early notable gainers among liquid option names on May 4th 05/04/23 Unusually active option classes on open May 4th 05/01/23 Early notable gainers among liquid option names on May 1st 03/16/23 Unusually active option classes on open March 16th PFE Pfizer $37.00 / -0.17 (-0.46%) 05/02/23 Unusually active option classes on open May 2nd 01/31/23 Unusually active option classes on open January 31st 01/11/23 Largest borrow rate increases among liquid names 01/10/23 Unusually active option classes on open January 10th OXY Occidental Petroleum $58.13 / -0.39 (-0.67%) 04/03/23 Unusually active option classes on open April 3rd 03/28/23 Unusually active option classes on open March 28th 03/08/23 Early notable gainers among liquid option names on March 8th 03/08/23 Unusually active option classes on open March 8th ONON On Holding $30.18 / -3.265 (-9.76%) 04/03/23 On Holding AG call volume above normal and directionally bullish 03/24/23 On Holding AG call volume above normal and directionally bullish 03/23/23 Unusually active option classes on open March 23rd MRK Merck $116.08 / -0.34 (-0.29%) 04/25/23 Merck call volume above normal and directionally bullish 04/17/23 Unusually active option classes on open April 17th 03/10/23 Early notable gainers among liquid option names on March 10th 01/10/23 Largest borrow rate increases among liquid names IQ iQIYI $5.50 / -0.48 (-8.03%) 05/12/23 iQiyi put volume heavy and directionally bearish 05/11/23 iQiyi put volume heavy and directionally bearish 05/10/23 iQiyi put volume heavy and directionally bearish 05/08/23 iQiyi put volume heavy and directionally bearish HZNP Horizon Therapeutics $96.35 / -15.91 (-14.17%) 05/16/23 Horizon Pharma put volume heavy and directionally bearish 04/24/23 Horizon Pharma put volume heavy and directionally bearish 02/10/23 Horizon Pharma put volume heavy and directionally bearish 02/07/23 Horizon Pharma call volume above normal and directionally bullish HD Home Depot $282.36 / -6.04 (-2.09%) 05/16/23 Unusually active option classes on open May 16th 03/17/23 Home Depot call volume above normal and directionally bullish 02/21/23 Unusually active option classes on open February 21st 01/19/23 Home Depot put volume heavy and directionally bearish GILD Gilead $78.33 / -0.01 (-0.01%) 05/03/23 Gilead call volume above normal and directionally bullish 04/27/23 Gilead options imply 3.8% move in share price post-earnings 02/03/23 Early notable gainers among liquid option names on February 3rd 02/02/23 Gilead options imply 3.5% move in share price post-earnings DAL Delta Air Lines $33.82 / +0.1 (+0.30%) 05/02/23 Delta Air Lines put volume heavy and directionally bearish 04/10/23 Unusually active option classes on open April 10th 03/29/23 Unusually active option classes on open March 29th 03/13/23 Delta Air Lines put volume heavy and directionally bearish CS Credit Suisse / + 03/20/23 Notable open interest changes for March 20th 03/17/23 Notable open interest changes for March 17th COF Capital One $90.95 / +1.87 (+2.10%) 05/16/23 Early notable gainers among liquid option names on May 16th 04/27/23 Capital One options imply 4.7% move in share price post-earnings 03/23/23 Capital One put volume heavy and directionally bearish CMCSA Comcast $39.73 / -0.48 (-1.19%) 03/01/23 Comcast call volume above normal and directionally bullish 02/06/23 Comcast put volume heavy and directionally bearish 02/03/23 Comcast put volume heavy and directionally bearish 01/19/23 Comcast put volume heavy and directionally bearish BIDU Baidu $132.75 / +5.11 (+4.00%) 05/11/23 Baidu call volume above normal and directionally bullish 05/04/23 Baidu call volume above normal and directionally bullish 03/24/23 Baidu call volume above normal and directionally bullish AMZN Amazon.com $113.41 / +2.16 (+1.94%) 05/12/23 Notable open interest changes for May 12th 05/11/23 Notable open interest changes for May 11th 05/02/23 Notable open interest changes for May 2nd 05/01/23 Notable open interest changes for May 1st AMGN Amgen $227.89 / -5.55 (-2.38%) 04/05/23 Early notable gainers among liquid option names on April 5th 02/17/23 Early notable gainers among liquid option names on February 17th 01/31/23 Amgen options imply 3.2% move in share price post-earnings
Periodicals	Muddy Waters short Chinook, says atrasentan 'highly unlikely' to be approved » 10:04 05/16/23 05/16 10:04 05/16/23 10:04 KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) , ABBV AbbVie $145.42 / -1.14 (-0.78%) Muddy Waters announced on… Muddy Waters announced on its website the that the firm is short Chinook Therapeutics (KDNY), citing its belief that it is "highly unlikely" that lead product candidate atrasentan will be approved by the FDA. "We conclude that atrasentan is inefficacious for chronic kidney disease. We also conclude that atrasentan has been shown to be harmful to patients' cardiovascular health. AbbVie (ABBV) and Chinook seem to have systemically manipulated research findings and presentation on atrasentan to obscure these trial results. Even if atrasentan were efficacious and safe, it would be unlikely to gain approval because a competing drug, sparsentan, has received accelerated and exclusive orphan drug approval by the US FDA for IgA nephropathy, the condition targeted in Chinook's only Phase 3 trial, the ALIGN study," the firm argues in a report summary posted to its site. In morning trading, Chinook shares are off their earlier lows but remain down $2.62, or 11%, at $20.77. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options KDNY ABBV KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) 05/16/23 Chinook drops 7% to $21.76 after Muddy Waters short report 05/16/23 Chinook Therapeutics weakness attributed to short call 05/16/23 Chinook Therapeutics enters partnership with Ionis Pharmaceuticals 04/11/23 Chinook Therapeutics announces voluntary pause in dosing o CHK-336 ABBV AbbVie $145.42 / -1.14 (-0.78%) 04/27/23 AbbVie says discontinuing cystic fibrosis programs due to lack of efficacy 04/27/23 AbbVie reports Q1 global Humira revenue $3.54B, down 25.2% on reported basis 04/25/23 Enanta sells 54.5% of future royalty payments from Mavyret/Maviret for $200M 04/21/23 AbbVie announces ELEVATE study meets all primary, secondary endpoints KDNY ABBV KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) 05/10/23 H.C. Wainwright Chinook Therapeutics price target raised to $32 from $31 at H.C. Wainwright 05/02/23 Guggenheim Chinook Therapeutics price target lowered to $35 from $43 at Guggenheim 03/06/23 Piper Sandler Chinook Therapeutics initiated with an Overweight at Piper Sandler 02/28/23 Guggenheim Guggenheim starts Chinook Therapeutics at Buy, 'bullish' on IgAN market ABBV AbbVie $145.42 / -1.14 (-0.78%) 05/02/23 Oppenheimer Vertex Pharmaceuticals price target raised to $410 from $350 at Oppenheimer 04/28/23 Guggenheim AbbVie price target lowered to $171 from $172 at Guggenheim 04/28/23 Wells Fargo AbbVie price target lowered to $195 from $200 at Wells Fargo 04/12/23 Barclays AbbVie price target raised to $160 from $155 at Barclays KDNY ABBV KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) 05/09/23 Chinook Therapeutics reports Q1 EPS (85c), consensus (79c) 02/27/23 Chinook Therapeutics reports Q4 EPS (90c), consensus (79c) ABBV AbbVie $145.42 / -1.14 (-0.78%) 04/27/23 AbbVie raises FY23 adjusted EPS view to $10.72-$11.12 from $10.62-$11.02 04/27/23 AbbVie reports Q1 adjusted EPS $2.46, consensus $2.46 04/26/23 Notable companies reporting before tomorrow's open 25 May KDNY ABBV KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) 05/16/23 Chinook's atrasentan shows no sign of renal repair, Muddy Water says 05/16/23 Muddy Waters announces short position in Chinook Therapeutics ABBV AbbVie $145.42 / -1.14 (-0.78%) 04/17/23 Allergan Aesthetics' CoolSculpting can lead to disfigurement, NY Times reports 02/06/23 AbbVie looking for next hit drug after competitors target Humira, WSJ reports 01/31/23 AbbVie's Humira drug faces competition in the U.S., FT reports 12/03/22 Buy AbbVie, stock still worth owning even as Humira fades, Barron's says ABBV ABBV AbbVie $145.42 / -1.14 (-0.78%) 04/27/23 What You Missed On Wall Street On Thursday 04/27/23 What You Missed On Wall Street This Morning 04/27/23 Fly Intel: Pre-market Movers 04/06/23 What You Missed On Wall Street On Thursday 05/21/23 PDUFA Date for Epcoritamab (DuoBody-CD3xCD20) 06/09/23 Chinook Therapeutics Inc ABBV ABBV AbbVie $145.42 / -1.14 (-0.78%) 04/27/23 Unusually active option classes on open April 27th 02/09/23 Unusually active option classes on open February 9th 01/18/23 Unusually active option classes on open January 18th
Hot Stocks	Chinook drops 7% to $21.76 after Muddy Waters short report 10:02 05/16/23 05/16 10:02 05/16/23 10:02 KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Events KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) 05/16/23 Chinook Therapeutics weakness attributed to short call 05/16/23 Chinook Therapeutics enters partnership with Ionis Pharmaceuticals 04/11/23 Chinook Therapeutics announces voluntary pause in dosing o CHK-336 02/15/23 Chinook Therapeutics appoints Andrew Oxtoby as CCO KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) 05/10/23 H.C. Wainwright Chinook Therapeutics price target raised to $32 from $31 at H.C. Wainwright 05/02/23 Guggenheim Chinook Therapeutics price target lowered to $35 from $43 at Guggenheim 03/06/23 Piper Sandler Chinook Therapeutics initiated with an Overweight at Piper Sandler 02/28/23 Guggenheim Guggenheim starts Chinook Therapeutics at Buy, 'bullish' on IgAN market KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) 05/09/23 Chinook Therapeutics reports Q1 EPS (85c), consensus (79c) 02/27/23 Chinook Therapeutics reports Q4 EPS (90c), consensus (79c) 25 May KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) 05/16/23 Chinook's atrasentan shows no sign of renal repair, Muddy Water says 05/16/23 Muddy Waters announces short position in Chinook Therapeutics 06/09/23 Chinook Therapeutics Inc
Periodicals	Chinook's atrasentan shows no sign of renal repair, Muddy Water says 10:02 05/16/23 05/16 10:02 05/16/23 10:02 KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Events KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) 05/16/23 Chinook Therapeutics weakness attributed to short call 05/16/23 Chinook Therapeutics enters partnership with Ionis Pharmaceuticals 04/11/23 Chinook Therapeutics announces voluntary pause in dosing o CHK-336 02/15/23 Chinook Therapeutics appoints Andrew Oxtoby as CCO KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) 05/10/23 H.C. Wainwright Chinook Therapeutics price target raised to $32 from $31 at H.C. Wainwright 05/02/23 Guggenheim Chinook Therapeutics price target lowered to $35 from $43 at Guggenheim 03/06/23 Piper Sandler Chinook Therapeutics initiated with an Overweight at Piper Sandler 02/28/23 Guggenheim Guggenheim starts Chinook Therapeutics at Buy, 'bullish' on IgAN market KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) 05/09/23 Chinook Therapeutics reports Q1 EPS (85c), consensus (79c) 02/27/23 Chinook Therapeutics reports Q4 EPS (90c), consensus (79c) 25 May KDNY Chinook Therapeutics $21.69 / -1.69 (-7.23%) 05/16/23 Muddy Waters announces short position in Chinook Therapeutics 06/09/23 Chinook Therapeutics Inc
Periodicals	Muddy Waters announces short position in Chinook Therapeutics 10:02 05/16/23 05/16 10:02 05/16/23 10:02 KDNY Chinook Therapeutics $21.60 / -1.78 (-7.61%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events KDNY Chinook Therapeutics $21.60 / -1.78 (-7.61%) 05/16/23 Chinook Therapeutics weakness attributed to short call 05/16/23 Chinook Therapeutics enters partnership with Ionis Pharmaceuticals 04/11/23 Chinook Therapeutics announces voluntary pause in dosing o CHK-336 02/15/23 Chinook Therapeutics appoints Andrew Oxtoby as CCO KDNY Chinook Therapeutics $21.60 / -1.78 (-7.61%) 05/10/23 H.C. Wainwright Chinook Therapeutics price target raised to $32 from $31 at H.C. Wainwright 05/02/23 Guggenheim Chinook Therapeutics price target lowered to $35 from $43 at Guggenheim 03/06/23 Piper Sandler Chinook Therapeutics initiated with an Overweight at Piper Sandler 02/28/23 Guggenheim Guggenheim starts Chinook Therapeutics at Buy, 'bullish' on IgAN market KDNY Chinook Therapeutics $21.60 / -1.78 (-7.61%) 05/09/23 Chinook Therapeutics reports Q1 EPS (85c), consensus (79c) 02/27/23 Chinook Therapeutics reports Q4 EPS (90c), consensus (79c) 25 May 06/09/23 Chinook Therapeutics Inc
Hot Stocks	Chinook Therapeutics weakness attributed to short call » 09:59 05/16/23 05/16 09:59 05/16/23 09:59 KDNY Chinook Therapeutics $21.60 / -1.78 (-7.61%) Shares of Chinook… Shares of Chinook Therapeutics are down $3.74, or 16%, to $19.66, which is being attributed by traders to the circulation of a short report targeting the company. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events KDNY Chinook Therapeutics $21.60 / -1.78 (-7.61%) 05/16/23 Chinook Therapeutics enters partnership with Ionis Pharmaceuticals 04/11/23 Chinook Therapeutics announces voluntary pause in dosing o CHK-336 02/15/23 Chinook Therapeutics appoints Andrew Oxtoby as CCO KDNY Chinook Therapeutics $21.60 / -1.78 (-7.61%) 05/10/23 H.C. Wainwright Chinook Therapeutics price target raised to $32 from $31 at H.C. Wainwright 05/02/23 Guggenheim Chinook Therapeutics price target lowered to $35 from $43 at Guggenheim 03/06/23 Piper Sandler Chinook Therapeutics initiated with an Overweight at Piper Sandler 02/28/23 Guggenheim Guggenheim starts Chinook Therapeutics at Buy, 'bullish' on IgAN market KDNY Chinook Therapeutics $21.60 / -1.78 (-7.61%) 05/09/23 Chinook Therapeutics reports Q1 EPS (85c), consensus (79c) 02/27/23 Chinook Therapeutics reports Q4 EPS (90c), consensus (79c) 25 May 06/09/23 Chinook Therapeutics Inc
Hot Stocks	Chinook Therapeutics enters partnership with Ionis Pharmaceuticals » 08:12 05/16/23 05/16 08:12 05/16/23 08:12 KDNY Chinook Therapeutics $23.38 / +0.01 (+0.04%) , IONS Ionis Pharmaceuticals $36.24 / +0.72 (+2.03%) Chinook Therapeutics… Chinook Therapeutics (KDNY) announced it has entered a collaboration agreement with Ionis Pharmaceuticals (IONS) for the discovery, development and commercialization of an antisense oligonucleotide therapy for a rare, severe chronic kidney disease with significant unmet medical need. The companies will leverage Chinook's precision medicine approach and deep expertise in nephrology and Ionis' extensive expertise in RNA-targeted therapeutics. "We are pleased to collaborate with Ionis on this preclinical discovery program as we continue to strengthen Chinook's position as the leading kidney disease company," said Andrew King, D.V.M, Ph.D., chief scientific officer of Chinook. "Developing an ASO therapy enhances our ability to target key genetic and molecular drivers and expands our precision medicine pipeline for rare severe chronic kidney diseases while continuing to pursue our goal of making dialysis and transplant unnecessary for people living with kidney disease." ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events KDNY IONS KDNY Chinook Therapeutics $23.38 / +0.01 (+0.04%) 04/11/23 Chinook Therapeutics announces voluntary pause in dosing o CHK-336 02/15/23 Chinook Therapeutics appoints Andrew Oxtoby as CCO IONS Ionis Pharmaceuticals $36.24 / +0.72 (+2.03%) 04/25/23 FDA approves Ionis Pharma/Biogen's QALSODY as first treatment in ALS 04/25/23 Biogen confirms FDA grants accelerated approval for Qalsody 04/24/23 AstraZeneca, Ionis announce eplontersen trial met all endpoints 03/29/23 Ionis Pharmaceuticals' IONIS-MAPTRx shows tau reduction efficacy in Alzheimer's KDNY IONS KDNY Chinook Therapeutics $23.38 / +0.01 (+0.04%) 05/10/23 H.C. Wainwright Chinook Therapeutics price target raised to $32 from $31 at H.C. Wainwright 05/02/23 Guggenheim Chinook Therapeutics price target lowered to $35 from $43 at Guggenheim 03/06/23 Piper Sandler Chinook Therapeutics initiated with an Overweight at Piper Sandler 02/28/23 Guggenheim Guggenheim starts Chinook Therapeutics at Buy, 'bullish' on IgAN market IONS Ionis Pharmaceuticals $36.24 / +0.72 (+2.03%) 05/04/23 Citi Ionis Pharmaceuticals upgraded to Neutral from Sell at Citi 05/04/23 Barclays Ionis Pharmaceuticals price target lowered to $37 from $40 at Barclays 04/20/23 Guggenheim Guggenheim previews Ionis' Eplontersen ATTR-PN update at AAN 03/21/23 Bernstein Ionis Pharmaceuticals initiated with an Underperform at Bernstein KDNY IONS KDNY Chinook Therapeutics $23.38 / +0.01 (+0.04%) 05/09/23 Chinook Therapeutics reports Q1 EPS (85c), consensus (79c) 02/27/23 Chinook Therapeutics reports Q4 EPS (90c), consensus (79c) IONS Ionis Pharmaceuticals $36.24 / +0.72 (+2.03%) 05/03/23 Ionis Pharmaceuticals reports Q1 EPS (87c), consensus (91c) 02/22/23 Ionis Pharmaceuticals sees FY23 revenue $575M, consensus $672.18M 02/22/23 Ionis Pharmaceuticals reports Q4 EPS (37c), consensus (92c) 25 May IONS IONS Ionis Pharmaceuticals $36.24 / +0.72 (+2.03%) 05/04/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/27/23 Biotech Alert: Searches spiking for these stocks today 03/24/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/16/23 Global Healthcare Conference 2023 12/22/23 PDUFA Date for Eplontersen 06/01/23 Ionis Pharmaceuticals Inc 06/09/23 Chinook Therapeutics Inc
Recommendations	Chinook Therapeutics price target raised to $32 from $31 at H.C. Wainwright » 06:23 05/10/23 05/10 06:23 05/10/23 06:23 KDNY Chinook Therapeutics $21.54 / +0.42 (+1.99%) H.C. Wainwright analyst… H.C. Wainwright analyst Ed Arce raised the firm's price target on Chinook Therapeutics to $32 from $31 and keeps a Buy rating on the shares post the Q1 results. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events KDNY Chinook Therapeutics $21.54 / +0.42 (+1.99%) 04/11/23 Chinook Therapeutics announces voluntary pause in dosing o CHK-336 02/15/23 Chinook Therapeutics appoints Andrew Oxtoby as CCO KDNY Chinook Therapeutics $21.54 / +0.42 (+1.99%) 05/02/23 Guggenheim Chinook Therapeutics price target lowered to $35 from $43 at Guggenheim 03/06/23 Piper Sandler Chinook Therapeutics initiated with an Overweight at Piper Sandler 02/28/23 Guggenheim Guggenheim starts Chinook Therapeutics at Buy, 'bullish' on IgAN market 02/28/23 Guggenheim Chinook Therapeutics initiated with a Buy at Guggenheim KDNY Chinook Therapeutics $21.54 / +0.42 (+1.99%) 05/09/23 Chinook Therapeutics reports Q1 EPS (85c), consensus (79c) 02/27/23 Chinook Therapeutics reports Q4 EPS (90c), consensus (79c) 11/10/22 Chinook Therapeutics reports Q3 EPS (83c), consensus (63c) 25 May 06/09/23 Chinook Therapeutics Inc
Earnings	Chinook Therapeutics reports Q1 EPS (85c), consensus (79c) » 16:05 05/09/23 05/09 16:05 05/09/23 16:05 KDNY Chinook Therapeutics $21.57 / +0.45 (+2.13%) Reports Q1 revenue $1.8M… Reports Q1 revenue $1.8M vs. $2.7M last year ."During the first quarter of 2023, we continued to advance our pipeline of clinical and preclinical programs for rare, severe chronic kidney diseases. We recently completed full enrollment of the phase 3 ALIGN clinical trial, are on track to initiate the phase 3 BION-1301 IgAN clinical trial mid-year and expect to report topline ALIGN results in the fourth quarter of this year," said Eric Dobmeier, president and chief executive officer of Chinook Therapeutics. "We also look forward to the upcoming 60th European Renal Association Congress being held June 15th - 18th, where we will present clinical data from the phase 1/2 trial of BION-1301 as well as the phase 1 trial of CHK-336 in healthy volunteers." ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events KDNY Chinook Therapeutics $21.57 / +0.45 (+2.13%) 04/11/23 Chinook Therapeutics announces voluntary pause in dosing o CHK-336 02/15/23 Chinook Therapeutics appoints Andrew Oxtoby as CCO KDNY Chinook Therapeutics $21.57 / +0.45 (+2.13%) 05/02/23 Guggenheim Chinook Therapeutics price target lowered to $35 from $43 at Guggenheim 03/06/23 Piper Sandler Chinook Therapeutics initiated with an Overweight at Piper Sandler 02/28/23 Guggenheim Guggenheim starts Chinook Therapeutics at Buy, 'bullish' on IgAN market 02/28/23 Guggenheim Chinook Therapeutics initiated with a Buy at Guggenheim KDNY Chinook Therapeutics $21.57 / +0.45 (+2.13%) 02/27/23 Chinook Therapeutics reports Q4 EPS (90c), consensus (79c) 11/10/22 Chinook Therapeutics reports Q3 EPS (83c), consensus (63c) 25 May 06/09/23 Chinook Therapeutics Inc
Recommendations	Chinook Therapeutics price target lowered to $35 from $43 at Guggenheim » 06:44 05/02/23 05/02 06:44 05/02/23 06:44 KDNY Chinook Therapeutics $19.86 / -0.14 (-0.70%) , TVTX Travere Therapeutics $22.59 / +1.03 (+4.78%) Guggenheim lowered the… Guggenheim lowered the firm's price target on Chinook Therapeutics (KDNY) to $35 from $43 and keeps a Buy rating on the shares after Travere Therapeutics (TVTX) announced that the DUPLEX study for Filspari in focal segmental glomerulosclerosis, or FSGS, failed to meet its primary efficacy endpoints. Filspari performed close to what the firm had expected, but the comparator irbesartan arm performed better than expected, leading to the negative overall results, says the analyst, who is removing all FSGS sales from the firm's Travere model and similarly removing FSGS sales for atrasentan from the firm's Chinook model given the similar mechanism of action between Filspari and atrasentan. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events TVTX KDNY TVTX Travere Therapeutics $22.59 / +1.03 (+4.78%) 05/01/23 Travere Therapeutics down 24% at $17.25 after announcing sparsentan study data 05/01/23 Travere Therapeutics' sparsentan study did not achieve primary efficacy 04/02/23 Travere Therapeutics announces interim analysis from Phase 3 PROTECT study 02/17/23 Ligand's partner Travere Therapeutics gets FDA accelerated approval of Filspari KDNY Chinook Therapeutics $19.86 / -0.14 (-0.70%) 04/11/23 Chinook Therapeutics announces voluntary pause in dosing o CHK-336 02/15/23 Chinook Therapeutics appoints Andrew Oxtoby as CCO 11/04/22 Chinook Therapeutics presents data from BION-1301, CHK-336 programs 11/03/22 Chinook Therapeutics: Atrasentan was well-tolerated in Phase 2 cohort KDNY TVTX KDNY Chinook Therapeutics $19.86 / -0.14 (-0.70%) 03/06/23 Piper Sandler Chinook Therapeutics initiated with an Overweight at Piper Sandler 02/28/23 Guggenheim Guggenheim starts Chinook Therapeutics at Buy, 'bullish' on IgAN market 02/28/23 Guggenheim Chinook Therapeutics initiated with a Buy at Guggenheim 02/28/23 H.C. Wainwright Chinook Therapeutics price target lowered to $31 from $33 at H.C. Wainwright TVTX Travere Therapeutics $22.59 / +1.03 (+4.78%) 05/02/23 Guggenheim Travere Therapeutics price target lowered to $23 from $40 at Guggenheim 04/10/23 Guggenheim Travere Therapeutics price target raised to $40 from $37 at Guggenheim 04/04/23 Barclays Travere risk/reward positive into FSGS data, says Barclays 03/13/23 Piper Sandler Travere Therapeutics price target lowered to $41 from $44 at Piper Sandler TVTX KDNY TVTX Travere Therapeutics $22.59 / +1.03 (+4.78%) 02/23/23 Travere Therapeutics reports Q4 EPS ($1.03), consensus ($1.07) 01/09/23 Travere Therapeutics sees Q4 net product sales $52M, consensus $57.15 KDNY Chinook Therapeutics $19.86 / -0.14 (-0.70%) 02/27/23 Chinook Therapeutics reports Q4 EPS (90c), consensus (79c) 11/10/22 Chinook Therapeutics reports Q3 EPS (83c), consensus (63c) 01 Mar 25 May TVTX TVTX Travere Therapeutics $22.59 / +1.03 (+4.78%) 05/01/23 Fly Intel: After-Hours Movers 02/21/23 What You Missed On Wall Street On Tuesday 02/21/23 What You Missed On Wall Street This Morning 05/04/23 Travere Therapeutics - TVTX 05/17/23 Travere Therapeutics Inc

12:36	Short Report: Bears reload on Mobileye after sharp gains in stock price»
16:24	What You Missed On Wall Street On Friday»
15:54	Bet On It: MGM Resorts considered potential buyer for Kindred Group»
15:37	Buy/Sell: Wall Street's top 10 stock calls this week»
12:01	What You Missed On Wall Street This Morning»

SRPT ...	PDUFA Date for SRP-9001
	Healthcare
HTHT	H World Group - HTHT

Get Full Fly Access